Published in Br J Pharmacol on May 01, 1975
Alpha 1-adrenergic agonists selectively suppress voltage-dependent K+ current in rat ventricular myocytes. Proc Natl Acad Sci U S A (1988) 1.50
Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart. Br J Pharmacol (1984) 1.11
Alpha 1-adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells. J Physiol (1992) 1.04
alpha-Sympathomimetic amines and calcium-mediated action potentials in guinea-pig ventricular muscle. Br J Pharmacol (1980) 0.89
Differences between the prejunctional effects of phenylephrine and clonidine in guinea-pig isolated atria. Br J Pharmacol (1984) 0.89
Cyclic AMP regulation of myosin isozymes in mammalian cardiac muscle. J Gen Physiol (1983) 0.88
Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog. Br J Pharmacol (1978) 0.87
The role of cyclic 3',5'-adenosine monophosphate (cyclic AMP) in the ability of sympathetic nerve stimulation to enhance growth and secretion in rat salivary glands in vivo. J Physiol (1976) 0.80
Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy. Br J Clin Pharmacol (1989) 0.78
Cardiac adrenoceptors at low temperature and the adrenoceptor interconversion hypothesis. Br J Pharmacol (1977) 0.77
Some characteristics of the inotropic effects of histamine H1- and H2-receptor agonists in comparison with those of alpha- and beta-adrenoceptor agonists. Agents Actions (1982) 0.75
Age-dependent differences in the positive inotropic effect of phenylephrine on rat isolated atria. Br J Pharmacol (1983) 0.75
The role of transmembrane calcium flux in the adrenergic response of the isolated frog heart [proceedings]. Br J Pharmacol (1977) 0.75
Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther (1963) 8.48
The effect of the duration of the action potential on contraction in the mammalian heart muscle. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 2.68
Interactions between sympathomimetic amines and blocking agents on the rat ventricle strip. Arch Int Pharmacodyn Ther (1966) 1.81
Membrane potential and slow inward current dependence of frog cardiac mechanical activity. Pflugers Arch (1972) 1.77
Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents. J Pharmacol Exp Ther (1968) 1.77
New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp technique. Experientia (1972) 1.68
Interactions of sympathomimetic drugs, propranolol and phentolamine, on atrial refractory period and contractility. Br J Pharmacol Chemother (1967) 1.27
Effects of noradrenaline and isoprenaline, in combination with - and -receptor blocking substances, on the action potential of cardiac Purkinje fibres. J Physiol (1973) 1.20
A positive inotropic effect of phenylephrine mediated through alpha adrenergic receptors. Life Sci (1967) 1.16
Propranolol-insensitive effects of epinephrine on action potential repolarization in electrically driven atria of the guinea pig. J Pharmacol Exp Ther (1971) 1.13
The positive inotropic effect of cyclic AMP. Adv Cyclic Nucleotide Res (1972) 1.02
Lack of relationship between myocardial cyclic AMP concentrations and inotropic effects of sympathomimetic amines. Br J Pharmacol (1971) 0.98
Characterization of -adrenoceptors in the myocardium. Br J Pharmacol (1973) 0.96
Analysis of the adrenergic receptors of pacemaker and myocardial cells. Eur J Pharmacol (1972) 0.92
Effect of phenylephrine on cardiac contractility and adenyl cyclase activity. Can J Physiol Pharmacol (1971) 0.89
Interactions of phenylephrine and theophylline in contractility and excitability of isolated rabbit left atria. Jpn J Pharmacol (1973) 0.83
Electrophysiological effects of phenylephrine on Purkinje fibres of sheep heart. Arch Int Pharmacodyn Ther (1972) 0.81
Mitochondrial control of nuclear apoptosis. J Exp Med (1996) 5.01
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med (1995) 4.88
Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med (1995) 4.20
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med (1996) 4.00
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest (1994) 3.51
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26
Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol (1996) 2.46
Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia (2009) 2.17
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem (1998) 2.11
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation (1991) 1.98
Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood (1995) 1.83
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia (2005) 1.71
Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron (2001) 1.69
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia (2010) 1.67
Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol (1996) 1.64
Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett (1996) 1.58
Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes. Cardiovasc Res (1998) 1.56
The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene (1997) 1.53
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia (2010) 1.48
[New therapeutic approachs in melanoma]. Rev Med Brux (2004) 1.40
Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol (2010) 1.38
[Rational and selective management of patients with anterior urethral stricture disease]. Actas Urol Esp (2011) 1.38
Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scand J Infect Dis (1996) 1.37
Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res (2009) 1.34
Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res (1997) 1.30
Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol (1995) 1.29
Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J (2000) 1.28
The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol (2001) 1.26
Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun (1993) 1.26
Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology (1999) 1.25
Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res (1994) 1.25
Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res (1996) 1.24
PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res (1998) 1.23
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene (2001) 1.22
Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation (1997) 1.21
Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med (2001) 1.20
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma. Ann Oncol (2013) 1.20
Effects of noradrenaline and isoprenaline, in combination with - and -receptor blocking substances, on the action potential of cardiac Purkinje fibres. J Physiol (1973) 1.20
Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation (1996) 1.19
Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations. J Cardiovasc Pharmacol (1982) 1.13
BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg (2008) 1.12
Beta- and alpha-cell dysfunction in type 2 diabetes. Horm Metab Res (2005) 1.12
Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol (1998) 1.11
Abdominoscrotal hydrocele: a reliable surgical technique. Urology (2000) 1.11
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res (1997) 1.10
Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab (2009) 1.10
Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Invest (2000) 1.10
C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. Cell Death Differ (2012) 1.10
The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene (1998) 1.09
Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol (1997) 1.08
Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats. J Physiol (1994) 1.08
Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol (1999) 1.08
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol (1998) 1.07
Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway. Cell Death Differ (2003) 1.07
An oscillatory current in sheep cardiac Purkinje fibers. Circ Res (1981) 1.05
Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol (1999) 1.05
The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups. Int J Neuropharmacol (1968) 1.03
Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patch-clamp study in guinea pig ventricular myocytes. Circulation (1991) 1.03
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat (2001) 1.01
Plasma membrane potential in thymocyte apoptosis. J Immunol (1999) 1.01
The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J (2001) 1.01
Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype. Br J Pharmacol (1991) 1.01
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab (2003) 1.01
Defective caspase-3 relocalization in non-small cell lung carcinoma. Oncogene (2001) 1.01
Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ (2007) 1.00
Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia (2013) 1.00
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab (2001) 1.00
Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia (2006) 1.00
Influence of postnatal-development on I(f) occurrence and properties in neonatal rat ventricular myocytes. Cardiovasc Res (1999) 1.00
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf (2010) 1.00
Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol (1995) 0.99
Identification, localization and functional activity of oxytocin receptors in epididymis. Mol Cell Endocrinol (2002) 0.99
Effects of Mycoplasma fermentans on the myelomonocytic lineage. Different molecular entities with cytokine-inducing and cytocidal potential. J Immunol (1996) 0.99
NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro. Diabetologia (2001) 0.99
Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol (2000) 0.98
USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis (2012) 0.98
The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.98
Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway. Oncogene (2007) 0.98
Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol (1990) 0.98
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene (2011) 0.96
The pacemaker current I(f) in single human atrial myocytes and the effect of beta-adrenoceptor and A1-adenosine receptor stimulation. Br J Pharmacol (1997) 0.95
The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J (2000) 0.95
Barium-induced spontaneous activity in sheep cardiac Purkinje cells. J Mol Cell Cardiol (1983) 0.94
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant (2014) 0.94
The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Br J Pharmacol (1996) 0.92
A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications. Gene Ther (2000) 0.92
Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol (1999) 0.92
Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes (2001) 0.91
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod (2002) 0.91
Blockade by burimamide of the restorative effect of histamine in tetrodotoxin-treated heart preparations. Br J Pharmacol (1976) 0.91
Frequency dependence of the alpha-adrenoceptor-mediated positive inotropic effect in guinea pig heart. Eur J Pharmacol (1976) 0.91
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol (2012) 0.90
Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am J Physiol Heart Circ Physiol (2001) 0.90
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev (2007) 0.90